As of June 16, 2025, Ocugen Inc (OCGN) reports a Net Margin of -1333.02%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Ocugen Inc's Net Margin
Over recent years, Ocugen Inc's Net Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2024-12-31 | -1333.02% |
| 2023-12-31 | -1045.03% |
| 2022-12-31 | -54550.00% |
This fluctuation highlights how Ocugen Inc manages its overall profitability and cost control over time.
Comparing Ocugen Inc's Net Margin to Peers
To better understand Ocugen Inc's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Ocugen Inc (OCGN) | -1333.02% |
| Regeneron Pharmaceuticals Inc (REGN) | 31.07% |
| Krystal Biotech Inc (KRYS) | 30.69% |
| Amgen Inc (AMGN) | 12.24% |
| Abbvie Inc (ABBV) | 7.59% |
| Gilead Sciences Inc (GILD) | 1.67% |
Compared to its competitors, Ocugen Inc's Net Margin is about average compared to peers, reflecting typical industry profitability.